摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-二氮杂二环[2.2.1]庚烷,2-(1,1-二甲基乙基)-,自由基离子(1+)(9CI) | 226988-19-8

中文名称
2,3-二氮杂二环[2.2.1]庚烷,2-(1,1-二甲基乙基)-,自由基离子(1+)(9CI)
中文别名
——
英文名称
(-)-(3S,4S,5S)-4,5-dihydroxy-3-hydroxymethylhexahydropyridazine
英文别名
(3R,4R,5R)-4,5-Dihydroxy-3-(hydroxymethyl)hexahydropyridazine;(3R,4R,5R)-4,5-Dihydroxy-3-hydroxymethylhexahydropyridazine;(-)-1-azafagomine;1-Azafagomine;D-azafagomine;azafagomine;(3R,4R,5R)-3-(Hydroxymethyl)hexahydropyridazine-4,5-diol;(3R,4R,5R)-3-(hydroxymethyl)diazinane-4,5-diol
2,3-二氮杂二环[2.2.1]庚烷,2-(1,1-二甲基乙基)-,自由基离子(1+)(9CI)化学式
CAS
226988-19-8
化学式
C5H12N2O3
mdl
——
分子量
148.162
InChiKey
PPPMSBCQTLJPKM-UOWFLXDJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    84.8
  • 氢给体数:
    5
  • 氢受体数:
    5

SDS

SDS:4af79a3e099d67d6cf8ffb9a8664f002
查看

反应信息

  • 作为反应物:
    描述:
    2,3-二氮杂二环[2.2.1]庚烷,2-(1,1-二甲基乙基)-,自由基离子(1+)(9CI)manganese(IV) oxide 、 sodium sulfate 作用下, 以 甲醇 为溶剂, 反应 2.0h, 以45%的产率得到(3R,4R,5R)-4,5-dihydroxy-3-hydroxymethyl-2,3,4,5-tetrahydropyridazine
    参考文献:
    名称:
    Hansen, Steen Uldall; Bols, Mikael, Journal of the Chemical Society. Perkin Transactions 2 (2001), 2000, # 4, p. 665 - 667
    摘要:
    DOI:
  • 作为产物:
    描述:
    (S)-2-acetoxymethyl-8-methyl-1,6,8-triazabicyclo[4.3.0]non-3-ene-7,9-dione 在 Oxone高氯酸1,1,1-三氟丙酮碳酸氢钠 、 sodium carbonate 、 一水合肼 作用下, 以 甲醇乙腈 为溶剂, 反应 27.0h, 生成 2,3-二氮杂二环[2.2.1]庚烷,2-(1,1-二甲基乙基)-,自由基离子(1+)(9CI)
    参考文献:
    名称:
    Chemoenzymatic Synthesis of Enantiopure 1-Azafagomine
    摘要:
    A new chemoenzymatic synthesis of both enantiomeric forms of the glycosidase inhibitor 1-azafagomine (1) is reported. The synthesis starts from the achiral starting materials pentadienol and methylurazol with the key steps being a hetero-Diels-Alder reaction followed by a lipase R/Novozym 435-catalyzed enantioselective esterification of the Diels-Alder adduct.
    DOI:
    10.1021/jo9907989
点击查看最新优质反应信息

文献信息

  • Enantiospecific Synthesis of 1-Azafagomine
    作者:Bettina V. Ernholt、Ib B. Thomsen、Anders Lohse、Igor W. Plesner、Kenneth B. Jensen、Rita G. Hazell、Xifu Liang、Astrid Jakobsen、Mikael Bols
    DOI:10.1002/(sici)1521-3765(20000117)6:2<278::aid-chem278>3.0.co;2-6
    日期:2000.1.17
    L-xylose was converted to (-)-1-azafagomine ((-)-1). Enzymatic and other routes to optically pure 1-azafagomine were also studied. Compound (-)-1 is a potent competitive glycosidase inhibitor, while (+)-1 has no biological activity. The inhibition of almond beta-glucosidase by (-)-1 was found to be slow owing to a slow binding step of inhibitor to enzyme, with no subsequent conformational rearrangement
    糖苷酶抑制剂1-azafagomine的两种对映体形式首次从D-和L-木糖开始合成。将D-木糖转化为2,3,5-三苄基呋喃糖,将其与氨基甲酸叔丁酯还原胺化后,可以高收率得到被保护的1-肼基-1-脱氧戊糖醇。N-乙酰化,4-OH的甲磺酸化,Boc基团的去除,环化和脱保护得到(+)-1-azafagomine((+)-1)。通过类似的反应序列,L-木糖被转化为(-)-1-氮杂花胺((-)-1)。还研究了通过酶促途径和其他途径获得光学纯的1-氮杂谷氨酰胺。化合物(-)-1是有效的竞争性糖苷酶抑制剂,而(+)-1没有生物活性。由于抑制剂与酶的结合步骤缓慢,因此发现(-)-1对杏仁β-葡萄糖苷酶的抑制作用较慢,没有随后的构象重排。发现结合和释放的速率常数分别为3.3 x 10(4)M(-1)s(-1)和0.011 s(-1),产生Ki = 0.33 microM。
  • Improvements to the Synthesis of Isofagomine, Noeuromycin, Azafagomine, and Isofagomine Lactam, and a Synthesis of Azanoeuromycin and 'Guanidine' Isofagomine
    作者:Peter J. Meloncelli、Robert V. Stick
    DOI:10.1071/ch06241
    日期:——

    Improvements in the preparation of a key imidazylate and the reduction of the derived nitrile have led to more efficient syntheses of isofagomine, noeuromycin, azafagomine, and isofagomine lactam. As well, a precursor of azafagomine has been converted into azanoeuromycin, and the nitrogen atom of isofagomine has been incorporated into a guanidine residue.

    通过改进关键咪唑盐酸盐的制备和衍生腈的还原,可以更有效地合成异法哥明、新霉素、氮法哥明和异法哥明内酰胺。此外,氮杂阿戈明的一种前体已转化为氮杂新霉素,而异阿戈明的氮原子已与胍残基结合。
  • Advances in the Synthesis of Homochiral (−)-1-Azafagomine and (+)-5-<i>epi</i>-1-Azafagomine. 1-<i>N</i>-Phenyl Carboxamide Derivatives of both Enantiomers of 1-Azafagomine: Leads for the Synthesis of Active α-Glycosidase Inhibitors.
    作者:M. José Alves、Flora T. Costa、Vera C. M. Duarte、Antonio Gil Fortes、José A. Martins、Nuno M. Micaelo
    DOI:10.1021/jo201486q
    日期:2011.12.2
    for functionalizing alkenes into molecules bearing a glucosyl framework. Homochiral (+)-5-epi-1-azafagomine was synthetized for the first time. Partial reductive cleavage of the phenyltriazolidinone moiety afforded new homochiral 1-N-phenyl carboxamide derivatives of 1-azafagomine. Both enantiomers of these derivatives were synthetized and tested, displaying a very good enzymatic inhibition toward baker's
    已经设计了一种新的快速制备手性同位(-)-1-氮杂胺和(+)-5-表位-1-氮杂胺的方法。Stoodley将带有2,3,4,6-四乙酰基葡萄糖基手性助剂的二烯的非对映选择性环加成到4-苯基-1,2,4-三唑-3,5-二酮与Bols协议合并,将烯烃官能化为带有葡萄糖基的分子框架。首次合成了手性(+)-5-表位-1-氮杂胺。苯基三唑烷酮部分的部分还原性裂解得到1-氮杂花果胺的新的同手性1- N-苯基羧酰胺衍生物。合成并测试了这些衍生物的两种对映异构体,显示出对面包酵母酵母α-葡萄糖苷酶的很好的酶抑制作用。1-的分子识别机理通过分子模拟研究了来自面包酵母的1-氮杂谷氨酰胺的N-苯基羧酰胺衍生物。将1- N-苯基羧酰胺基团的芳香环有效填充到酶活性位点的疏水亚位点(口袋)中,似乎是导致与未衍生化的(-)-1-azafagomine和( +)-1-氮杂胺。
  • Chemoenzymatic Synthesis of Enantiopure 1-Azafagomine
    作者:Xifu Liang、Mikael Bols
    DOI:10.1021/jo9907989
    日期:1999.11.1
    A new chemoenzymatic synthesis of both enantiomeric forms of the glycosidase inhibitor 1-azafagomine (1) is reported. The synthesis starts from the achiral starting materials pentadienol and methylurazol with the key steps being a hetero-Diels-Alder reaction followed by a lipase R/Novozym 435-catalyzed enantioselective esterification of the Diels-Alder adduct.
  • Hansen, Steen Uldall; Bols, Mikael, Journal of the Chemical Society. Perkin Transactions 2 (2001), 2000, # 4, p. 665 - 667
    作者:Hansen, Steen Uldall、Bols, Mikael
    DOI:——
    日期:——
查看更多